Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for OK Biotech Co., Ltd. (4155.TW), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
8.76
P/B ratioShare price divided by book value per share.
0.81
P/S ratioMarket value divided by annual revenue.
1.26
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
9.01
EV / RevenueEnterprise value against annual revenue.
1.76
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
11.42%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
31.13%
Operating marginRevenue left after operating costs.
11.85%
Net marginRevenue left after every cost, including tax and interest.
15.76%
Return on equityProfit as a percentage of shareholders’ equity.
10.29%
Return on assetsProfit as a percentage of total assets.
3.59%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.40
Quick ratioThe same, excluding inventory.
1.51
Debt to equityTotal borrowings against shareholders’ equity.
0.41
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$1.89
Book value per shareShareholders’ equity divided by shares outstanding.
$20.48
Shares outstandingShares currently issued.
117,162,283
Market capitalisationShare price times shares outstanding.
$1.94B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
62
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
1.86%
Payout ratioShare of profit paid out as dividends.
16.29%
OK Biotech Co., Ltd. (4155.TW) statistics — frequently asked questions
What is OK Biotech Co., Ltd.'s P/E ratio?
OK Biotech Co., Ltd. (4155.TW) trades on a price-to-earnings ratio of 8.76.
What is OK Biotech Co., Ltd.'s return on equity?
OK Biotech Co., Ltd. (4155.TW) reports a return on equity of 10.29%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does OK Biotech Co., Ltd. carry?
OK Biotech Co., Ltd. (4155.TW) has a debt-to-equity ratio of 0.41, which compares total borrowings with shareholders' equity.
What is OK Biotech Co., Ltd.'s profit margin?
OK Biotech Co., Ltd. (4155.TW) keeps 15.76% of revenue as net profit after every cost, including tax and interest.